Hengyu Biopharmaceutical (Shandong) Co., Ltd., which has been established into a comprehensive enterprise that integrates the R&D, production, application and sales of marine biological nucleic acid drug raw materials, medical devices and medical beauty products, is a leading biotechnology company in the industry in China that focuses on the application research and development of marine biological raw materials. 

As a leading enterprise in renewable new material PDRN/PN industry in China, Hengyu Biopharmaceutical is the first in China that has completed the construction of a medical grade PDRN/PN "industry, university, research, use and sales" industrial ecosystem, has proactively promoted the development and application of three categories of PDRN/PN medical devices and has owned leading advantages in R&D, production and application design and innovation capabilities in the fields of medical devices and medical beauty 

Multinational platform, PDRN/PN original research patent 

Independent innovation and scientific and technological innovation, Hengyu Biopharmaceutical (Shandong) Co., Ltd., which has built a medical level PDRN/PN transnational scientific research platform, set up a high specification nucleic acid research institute, established a national PDRN "national team" and continued to introduce international top talents in the field of PDRN/PN and international cooperation, is committed to building a leading echelon and research and development application sharing platform in the international biological nucleic acid scientific research field in order to provide technical support and solutions for the research of marine biological nucleic acid drugs and the development and application of regenerative medicine in China.

Focusing on the world and high-end innovative type leading advantages 

Zhengyu Biotechnology, a Haikou production base, has been approved for the production of national Class II medical devices, has achieved the domestic independent mass production of PDRN multi-category medical devices and international source supply, and has taken the lead in completing the design and application of PDRN/PN Class III medical devices.  

Based on the "bridgehead" advantage of Hainan Free Trade in China, it focus on the international strategic planning of PDRN/PN leading innovative application, qualification certification, landing operation, import and export of high-end medical devices and new medical products. 

National promotion plan of PDRN application 

Construction of PDRN application platform: MIGO aesthetic medicine institution which has been operated for nearly ten years; The first Sino-Korean joint venture medical institution in Shandong Free Trade Zone - Korean Medical Beauty, operating based on the international standard, is committed to the promotion, application and nationwide layout of PDRN/PN light aesthetic medicine, and its own brand medical product, aesthetic medicine, cosmetics, food and other efficacy products. 

Based on the concept of constant and successive Hengyu, Hengyu will continue to work hard for the future, and deeply cultivate the field of regenerative medicine and continue to make breakthroughs based on independent innovation and scientific and technological innovation and with domestic and international cooperation as a bridge, so as to fully promote the localization of PDRN/PN in China.

Practice corporate social responsibility, make progress with the society, and strive for a better human life.

Trace the source of marine bioactive substances, make access to the national medical system, tackle major international issues and build industry standards, construct international certification and application platform network, and explore more application schemes of biological nucleic acid.

A reliable enterprise;

An enterprise that delivers health and creates beauty! 

Strive to realize the lasting dream of health and beauty of the whole society! 

About PDRN/PN

Click the lower right corner of the video to view it in full screen 

PDRN is a mixture of deoxyribonucleic acid, which is one of the important complexes for the generation of DNA raw materials in cells, and PDRN is provided with a special ability to promote the recovery of skin after transplantation, cell regeneration, wound recovery, etc.

In 2008, it was approved to be used as a tissue repair compound for the first time in Italy, and in recent years, because of the magical effect of PDRN, PDRN mesotherapy has become a popular project for skin clinics and joint cavity repair products. At present, the research and application of PDRN in China is still in the development stage.

Nucleic acid drug activity promotion and regenerative therapeutic drugs can be used in medical cosmetology, skin care products, health care products and other anti-aging industries, and in the future, they will mainly play a role at the gene level, the precise targeting and specificity can be provided, and its application prospects are very broad. 

Become the world's leading supplier of 

PDRN medical-grade biological 

raw materials

Advanced medical device manufacturer